The methylation statuses at the PARD6G-AS1 and GCSAML iDMRs were perturbed in the methylomes of hematopoietic cancers, with both hypo- and hypermethylated profiles observed in different types of malignancies (Figure 9). The gene discussed is PARD6G; the disease is hematopoietic and lymphoid cell neoplasm.